Episode
Women’s Health, Digital Therapeutics, and Driving Change in Pharma: Jessica Federer
- Podcast
- from Dreamers to Disruptors
- Published
- May 10, 2025
- Duration seconds
- 2646
- Processing state
not_requested- Canonical source
- https://rss.com/podcasts/from-dreamers-to-disruptors/2022101
Actions
POST https://stenobird.com/v1/public/podcasts/from-dreamers-to-disruptors-7329003/episodes/women-s-health-digital-therapeutics-and-driving-change-in-pharma-jessica-federer/transcription-requests
Idempotently request low-priority transcript generation for this episode.GET https://stenobird.com/podcast/from-dreamers-to-disruptors-7329003/women-s-health-digital-therapeutics-and-driving-change-in-pharma-jessica-federer.md
Read the agent-friendly Markdown representation of this episode resource.
Summary
As Bayer’s first Chief Digital Officer, Jessica Federer is a true pioneer in life sciences. An early driver of digital transformation in clinical research and a champion for women’s health, she has a unique grasp on the challenges we face, and the opportunities waiting to be realized. Listen as Medidata CEO Anthony Costello sits down with Jessica to explore her exceptional career, from her work to uplift women’s voices in the industry and tackle gender-based inequalities in healthcare, to the potential of AI, digital therapeutics, and other emerging technologies. Jessica shares her insights into the shocking underrepresentation of women in clinical trials, and why their inclusion is essential for our understanding of conditions including autoimmune diseases and Alzheimer’s. She and Anthony explore roadblocks to digital adoption in clinical trials, and how pharma companies can promote innovative treatments like precision medicine to transform patient experiences and outcomes. Visit our website : www.medidata.com Read our blog : Clinical Minds Follow Medidata: LinkedIn , Instagram , X , YouTube Follow Anthony: LinkedIn Follow Jessica : LinkedIn , Instagram , X , Bluesky